Resmed (RMD) and Oura announced they are partnering to expand access to sleep health education and pathways to care. By connecting consumer-generated wellness insights with Resmed’s sleep health resources, Resmed and Oura are helping Oura Members take a more informed next step to better understand their sleep health.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMD:
- Analyst Maintains Hold on ResMed as Noctrix Acquisition Offers Limited Incremental Growth Amid Competitive Risks
- The Week That Was, The Week Ahead: Macro and Markets, May 10
- ResMed Earnings Call Highlights Margin Strength, Growth
- ResMed price target lowered to $225 from $254 at Baird
- ResMed price target lowered to $235 from $265 at Stifel